series-c-plus
Stage
1
Investors
About
Impel NeuroPharma develops intranasal drug delivery technologies, including the Precision Olfactory Delivery (POD) platform, to enable rapid and targeted delivery of therapeutics to the central nervous system for treating migraine and other neurological disorders.
Explore Impel NeuroPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.